This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies. Objectives: Risk ...
Experts weigh neoadjuvant vs adjuvant immunotherapy in resectable lung cancer, balancing PD‑L1, pCR, surgery timing, and toxicity. In your practice, how are you evaluating which patients will actually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results